Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - furosemide 10 mg/ml - solution for infusion - 10 mg/ml - active: furosemide 10 mg/ml excipient: mannitol sodium hydroxide water for injection - oedema lasix is indicated in adults, infants and children for the treatment of oedema associated with congestive heart failure, cirrhosis of the liver and renal disease including the nephrotic syndrome. lasix is particularly useful when an agent with greater diuretic potential than that of those commonly employed is desired. parenteral therapy should be reserved for patients unable to take oral medication or for patients in emergency clinical situations. lasix injection is also indicated as adjunctive therapy in acute pulmonary oedema and cerebral oedema where intense and rapid onset of diuresis is desired. if gastrointestinal absorption is impaired or oral medication is not practical for any reason, lasix is indicated by the intravenous route. parenteral use should be replaced with oral lasix as soon as practical.

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - pregabalin 100mg;   - capsule - 100 mg - active: pregabalin 100mg   excipient: colloidal silicon dioxide   gelatin   iron oxide red   lactose monohydrate maize starch purified talc purified water   sodium laurilsulfate   tekprint black sw-9008 tekprint black sw-9009 titanium dioxide  

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - pregabalin 150mg;   - capsule - 150 mg - active: pregabalin 150mg   excipient: colloidal silicon dioxide   gelatin   lactose monohydrate maize starch purified talc purified water   sodium laurilsulfate   tekprint black sw-9008 tekprint black sw-9009 titanium dioxide  

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - pregabalin 200mg;   - capsule - 200 mg - active: pregabalin 200mg   excipient: colloidal silicon dioxide   gelatin   iron oxide red   lactose monohydrate maize starch purified talc purified water   sodium laurilsulfate   tekprint black sw-9008 tekprint black sw-9009 titanium dioxide  

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - pregabalin 225mg;   - capsule - 225 mg - active: pregabalin 225mg   excipient: colloidal silicon dioxide   gelatin   iron oxide red lactose monohydrate maize starch purified talc purified water   sodium laurilsulfate   tekprint black sw-9008 tekprint black sw-9009 titanium dioxide  

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - pregabalin 25mg;   - capsule - 25 mg - active: pregabalin 25mg   excipient: colloidal silicon dioxide   gelatin   lactose monohydrate maize starch purified talc purified water   sodium laurilsulfate   tekprint black sw-9008 tekprint black sw-9009 titanium dioxide  

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - pregabalin 300mg;   - capsule - 300 mg - active: pregabalin 300mg   excipient: colloidal silicon dioxide   gelatin   iron oxide red lactose monohydrate maize starch purified talc purified water   sodium laurilsulfate   tekprint black sw-9008 tekprint black sw-9009 titanium dioxide  

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - pregabalin 50mg;   - capsule - 50 mg - active: pregabalin 50mg   excipient: colloidal silicon dioxide   gelatin   lactose monohydrate maize starch purified talc purified water   sodium laurilsulfate   tekprint black sw-9008 tekprint black sw-9009 titanium dioxide  

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - pregabalin 75mg;   - capsule - 75 mg - active: pregabalin 75mg   excipient: colloidal silicon dioxide   gelatin   iron oxide red lactose monohydrate maize starch purified talc purified water   sodium laurilsulfate   tekprint black sw-9008 tekprint black sw-9009 titanium dioxide  

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - meningococcal polysaccharide 48ug (4 µg of each of groups a, c, y & w-135, each separately conjugated to diphtheria toxoid, 48 µg total) - solution for injection - 4 µg each/0.5 ml - active: meningococcal polysaccharide 48ug (4 µg of each of groups a, c, y & w-135, each separately conjugated to diphtheria toxoid, 48 µg total) excipient: dibasic sodium phosphate monobasic sodium phosphate sodium chloride water for injection - menactra vaccine is indicated for active immunisation in individuals from 9 months through 55 years of age for the prevention of invasive meningococcal disease caused by n. meningitidis serogroups a, c, y and w-135. menactra vaccine is not indicated for the prevention of meningitis caused by other microorganisms or for the prevention of invasive meningococcal disease caused by n meningitidis serogroup b. menactra vaccine is not indicated for treatment of meningococcal infections. menactra vaccine is not indicated for immunisation against diphtheria.